on daily we see a nice hammer
EVON, Pa., Aug. 31, 2018 (GLOBE NEWSWIRE) -- Zynerba Pharmaceuticals, Inc. (ZYNE), the leader in innovative pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders, today announced that Zynerba’s Chief Executive Officer, Armando Anido will present a company overview at the 20th Annual Global Investment Conference sponsored by H.C. Wainwright & Co., L.L.C. on September 5, 2018 at 8:45 AM EDT at the St. Regis New York. A live webcast of the presentation will be accessible on the Investor Relations page of www.zynerba.com. A replay of the webcast will be available for 90 days following the conclusion of the event.
Future cash flow value 114.00 USD
EVON, Pa., Aug. 31, 2018 (GLOBE NEWSWIRE) -- Zynerba Pharmaceuticals, Inc. (ZYNE), the leader in innovative pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders, today announced that Zynerba’s Chief Executive Officer, Armando Anido will present a company overview at the 20th Annual Global Investment Conference sponsored by H.C. Wainwright & Co., L.L.C. on September 5, 2018 at 8:45 AM EDT at the St. Regis New York. A live webcast of the presentation will be accessible on the Investor Relations page of www.zynerba.com. A replay of the webcast will be available for 90 days following the conclusion of the event.
Future cash flow value 114.00 USD
הערה:
daily hammer
עסקה סגורה: הגיע לסטופ